New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
On January 5, 2022, Eagle Pharmaceuticals announced the launch of an AP-rated generic version of Par Pharmaceutical’s Vasostrict (vasopressin) injection on January 17, 2022.
Download PDF
Return to publications
